Alteplase biosimilar (Scienture)

阿替普酶生物类似药(Scienture)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAlteplase biosimilar (Scienture)

Drug Alias NameSCN-106

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionPlasminogen stimulants

TargetsPlasminogen

Therapy Area/IndicationsIschemic StrokeCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesScienture Inc

China Registration ClassN/A

Develop Information

Active CompaniesScienture Inc

Inactive CompaniesN/A

Active IndicationsIschemic Stroke

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A